News

Many types of motile cells need to propel themselves through confined spaces filled with viscous liquid. Mathematical models of the motion of cells in viscous liquids are helping scientists to design artificial microswimmers for numerous applications including targeted drug delivery.

The Gamaleya Center and the Russian Direct Investment Fund have announced that Sputnik V – the world's first registered vaccine against COVID-19 – demonstrates an efficacy rate of ~92%.

Use of thyroid hormone to boost hepatocyte proliferation enhanced the efficiency of CRISPR/Cas9-mediated gene correction in the mouse liver. This may be a strategy to enhance gene repair within the liver, according to a new study.

Scientists from the Skolkovo Institute of Science and Technology have found that both MNs and the chemical space built around them were more effective than empirical solutions proposed until then.

A clinical trial designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug pembrolizumab will expand its cohort after promising preliminary data was presented.

A new approach to cancer treatment involves chemotherapy and immunotherapy into a biomaterial-based cancer vaccine that can be injected adjacent to a tumor site.

A pre-emptive memory management system can speed up data-intensive simulations by 2.5 times by eliminating delays due to slow data delivery. The development elegantly and transparently addresses one of the most stubborn bottlenecks in modern supercomputing – delivering data from memory fast enough to keep up with computations.

Scientists reviewed studies of three essential membrane proteins that monitor not only LPS biosynthesis inside the cell, but also transport to, and proper assembly at the cell surface.

The Institute of Cancer Research, has strongly welcomed the approval by the European Commission of the targeted drug olaparib for men with advanced prostate cancers with genetic alterations in BRCA1 or BRCA2.

Researchers have shown that nanoparticles could be used to deliver drugs to the brain to treat neurodegenerative diseases.